Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines ; volume:18 ; number:1 ; day:20 ; month:6 ; year:2011 ; pages:1-15 ; date:12.2011
Journal of biomedical science ; 18, Heft 1 (20.6.2011), 1-15, 12.2011
- Urheber
-
Wen, Chih-Chun
Chen, Hui-Ming
Chen, Swey-Shen
Huang, Li-Ting
Chang, Wei-Ting
Wei, Wen-Chi
Chou, Li-Chen
Arulselvan, Palanisamy
Wu, Jin-Bin
Kuo, Sheng-Chu
Yang, Ning-Sun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1423-0127-18-44
- URN
-
urn:nbn:de:101:1-2021080706552409208185
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wen, Chih-Chun
- Chen, Hui-Ming
- Chen, Swey-Shen
- Huang, Li-Ting
- Chang, Wei-Ting
- Wei, Wen-Chi
- Chou, Li-Chen
- Arulselvan, Palanisamy
- Wu, Jin-Bin
- Kuo, Sheng-Chu
- Yang, Ning-Sun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Dendritic cell-based immunotherapy : implications for novel vaccines from hSIGN and HUT9 mice
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma
Current status of dendritic cell-based tumor vaccination
Mechanism of dendritic cell-based vaccination against Leishmania major
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
P18-03. Dendritic cell-based immune therapy against HIV-1
Research progress on dendritic cell vaccines in cancer immunotherapy
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds
Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
Dendritic cell- and T cell-based immune therapies against Ebola virus infection